UK biotechs smash 2020 in­vest­ment records, sur­pass­ing San Diego in VC and IPO rais­es

As stocks tum­ble amid a vi­cious biotech bear mar­ket, the UK has found some­thing to cel­e­brate: Last year, UK-based biotechs smashed the in­vest­ment records they set in 2020, rais­ing a mam­moth $6.04 bil­lion (£4.5 bil­lion) in 2021 and sur­pass­ing San Diego in terms of ven­ture and IPO fund­ing.

That’s a 60% in­crease from 2020 in pub­lic and pri­vate fund­ing, ac­cord­ing to the lat­est re­port pub­lished by the UK’s BioIn­dus­try As­so­ci­a­tion (BIA) and Clar­i­vate.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER